Santin AD - Search Results

1

Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma.

Chow RD, Michaels T, Bellone S, Hartwich TMP, Bonazzoli E, Iwasaki A, Song E, Santin AD. Chow RD, et al. Among authors: santin ad. Cancer Discov. 2023 Feb 6;13(2):312-331. doi: 10.1158/2159-8290.CD-22-0686. Cancer Discov. 2023. PMID: 36301137 Free PMC article.

2

The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.

Santin AD, Cane' S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T, Pecorelli S. Santin AD, et al. Cancer. 2003 Nov 1;98(9):1898-904. doi: 10.1002/cncr.11753. Cancer. 2003. PMID: 14584072 Free article.

3

Current treatment options for endometrial cancer.

Santin AD, Bellone S, O'Brien TJ, Pecorelli S, Cannon MJ, Roman JJ. Santin AD, et al. Expert Rev Anticancer Ther. 2004 Aug;4(4):679-89. doi: 10.1586/14737140.4.4.679. Expert Rev Anticancer Ther. 2004. PMID: 15270671 Review.

4

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, Roman JJ, Burnett A, Cannon MJ, Pecorelli S. Santin AD, et al. Cancer Res. 2005 May 15;65(10):4334-42. doi: 10.1158/0008-5472.CAN-04-3472. Cancer Res. 2005. PMID: 15899825 Free article.

5

Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.

Santin AD, Bellone S, Van Stedum S, Bushen W, Palmieri M, Siegel ER, De Las Casas LE, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Cancer. 2005 Oct 1;104(7):1391-7. doi: 10.1002/cncr.21308. Cancer. 2005. PMID: 16116605 Free article.

6

Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.

Kim KH, Dishongh R, Santin AD, Cannon MJ, Bellone S, Nakagawa M. Kim KH, et al. Among authors: santin ad. Cancer Immun. 2006 Jun 30;6:9. Cancer Immun. 2006. PMID: 16808432

7

Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).

Santin AD, Bellone S, Marizzoni M, Palmieri M, Siegel ER, McKenney JK, Hennings L, Comper F, Bandiera E, Pecorelli S. Santin AD, et al. Cancer. 2007 Apr 1;109(7):1312-22. doi: 10.1002/cncr.22536. Cancer. 2007. PMID: 17326053 Free article.

8

A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.

Wang X, Santin AD, Bellone S, Gupta S, Nakagawa M. Wang X, et al. Among authors: santin ad. Cancer Immunol Immunother. 2009 Feb;58(2):301-8. doi: 10.1007/s00262-008-0525-2. Epub 2008 Apr 30. Cancer Immunol Immunother. 2009. PMID: 18446336 Free PMC article. Clinical Trial.

9

Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.

Bellone S, Shah HR, McKenney JK, Stone PJ, Santin AD. Bellone S, et al. Among authors: santin ad. Am J Obstet Gynecol. 2008 Sep;199(3):e7-e10. doi: 10.1016/j.ajog.2008.04.012. Epub 2008 Jun 12. Am J Obstet Gynecol. 2008. PMID: 18550023

10

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.

Santin AD, Bellone S, Roman JJ, McKenney JK, Pecorelli S. Santin AD, et al. Int J Gynaecol Obstet. 2008 Aug;102(2):128-31. doi: 10.1016/j.ijgo.2008.04.008. Epub 2008 Jun 16. Int J Gynaecol Obstet. 2008. PMID: 18555254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters